Virtus ETF Advisers’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-241
| Closed | -$5.21K | – | 443 |
|
|
2023
Q3 | $5.21K | Sell |
241
-24
| -9% | -$942 | ﹤0.01% | 434 |
|
|
2023
Q2 | $17.9K | Sell |
265
-3
| -1% | -$1.24K | 0.01% | 435 |
|
|
2023
Q1 | $125K | Sell |
268
-104
| -28% | -$55K | 0.07% | 325 |
|
|
2022
Q4 | $149K | Sell |
372
-94
| -20% | -$36K | 0.08% | 347 |
|
|
2022
Q3 | $152K | Buy |
466
+3
| +0.6% | +$966 | 0.06% | 351 |
|
|
2022
Q2 | $122K | Buy |
463
+1
| +0.2% | +$255 | 0.05% | 380 |
|
|
2022
Q1 | $139K | Sell |
462
-27
| -6% | -$9.41K | 0.06% | 240 |
|
|
2021
Q4 | $172K | Buy |
489
+160
| +49% | +$49.8K | 0.07% | 272 |
|
|
2021
Q3 | $84K | Sell |
329
-18
| -5% | -$6.38K | 0.04% | 388 |
|
|
2021
Q2 | $231K | Buy |
347
+74
| +27% | +$42.6K | 0.1% | 240 |
|
|
2021
Q1 | $237K | Buy |
273
+4
| +1% | +$4.26K | 0.1% | 297 |
|
|
2020
Q4 | $249K | Sell |
269
-54
| -17% | -$56.8K | 0.1% | 314 |
|
|
2020
Q3 | $332K | Sell |
323
-44
| -12% | -$47.3K | 0.17% | 202 |
|
|
2020
Q2 | $372K | Buy |
367
+59
| +19% | +$54.8K | 0.18% | 227 |
|
|
2020
Q1 | $268K | Sell |
308
-45
| -13% | -$44.7K | 0.11% | 243 |
|
|
2019
Q4 | $378K | Buy |
353
+104
| +42% | +$106K | 0.06% | 278 |
|
|
2019
Q3 | $230K | Sell |
249
-14
| -5% | -$15.4K | 0.05% | 222 |
|
|
2019
Q2 | $297K | Sell |
263
-11
| -4% | -$12K | 0.06% | 218 |
|
|
2019
Q1 | $372K | Sell |
274
-33
| -11% | -$44.8K | 0.79% | 41 |
|
|
2018
Q4 | $355K | Sell |
307
-14
| -4% | -$15.7K | 0.06% | 88 |
|
|
2018
Q3 | $487K | Sell |
321
-228
| -42% | -$351K | 0.05% | 130 |
|
|
2018
Q2 | $860K | Sell |
549
-181
| -25% | -$236K | 0.76% | 16 |
|
|
2018
Q1 | $844K | Buy |
730
+388
| +113% | +$511K | 0.73% | 66 |
|
|
2017
Q4 | $405K | Sell |
342
-109
| -24% | -$137K | 0.51% | 51 |
|
|
2017
Q3 | $607K | Buy |
451
+41
| +10% | +$43.2K | 0.08% | 78 |
|
|
2017
Q2 | $331K | Sell |
410
-140
| -25% | -$97.5K | 0.05% | 97 |
|
|
2017
Q1 | $339K | Buy |
550
+53
| +11% | +$32.3K | 0.06% | 126 |
|
|
2016
Q4 | $266K | Sell |
497
-98
| -16% | -$48.9K | 0.08% | 125 |
|
|
2016
Q3 | $308K | Hold |
595
| – | – | 0.15% | 97 |
|
|
2016
Q2 | $244K | Buy |
595
+266
| +81% | +$122K | 0.18% | 96 |
|
|
2016
Q1 | $175K | Buy |
+329
| New | +$164K | 0.24% | 105 |
|
Other funds holding KYNB
AC
Virtus ETF Advisers's KYNB Position: Q4 2023 in Review
Virtus ETF Advisers sold out of Kyntra Bio (KYNB) in Q4 2023, closing a stake of 241 shares — an estimated $5.21K sold.
Virtus ETF Advisers first reported a position in KYNB in Q1 2016 and held it in 31 quarters. The position peaked at $860K in Q2 2018. 100 funds tracked by Wall St. Rank hold KYNB as of Q4 2023.
- Virtus ETF Advisers reported no remaining Kyntra Bio position as of Q4 2023 after selling out during the quarter.
- Virtus ETF Advisers sold 241 Kyntra Bio shares in Q4 2023, an estimated $5.21K.
- Virtus ETF Advisers first reported a position in Kyntra Bio in Q1 2016 and held it in 31 quarters.
- Virtus ETF Advisers's Kyntra Bio position peaked at $860K in Q2 2018.
- 100 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2023.
Based on Virtus ETF Advisers's 13F filing for Q4 2023, filed 15 Feb 2024.